PMID: 3763137Jul 1, 1986Paper

Treatment of facial spasm with botulinum toxin. An interim report

Ophthalmology
B R Frueh, D C Musch

Abstract

Forty-eight patients were given serial injections of botulinum toxin in their eyelids for treatment of eyelid spasm during a two-year interval. Ninety-four percent obtained relief of spasm from botulinum toxin injection. The duration of the spasm-free interval as well as the incidence of ptosis and of diplopia was dose dependent. The marked increase in the incidence of these side effects with only a small increase in the duration of the spasm-free interval, when a dose of 25 units per lid was used, leads the authors to conclude that this dose is too high and should not be used. Since diplopia was most commonly caused by paresis of the inferior oblique muscle, and since blepharospasm usually can be controlled by excising the upper lid protractors, further studies are required to determine whether lower lid injection is necessary and, if it is found to be so, whether injecting only the lateral portion of the lid would be adequate.

References

May 15, 1985·American Journal of Ophthalmology·N ShorrJ Kopelman

❮ Previous
Next ❯

Citations

Nov 1, 1990·Annals of Neurology·K A ManningP A Sibony
Sep 1, 1992·Muscle & Nerve·D M YoshimuraA B Scott
Aug 3, 2005·Japanese Journal of Ophthalmology·Anuchit PoonyathalangUraiwan Jamnansiri
Nov 30, 2000·Current Treatment Options in Neurology·D R Boghen, R L Lesser
Aug 1, 1996·Clinical Neurology and Neurosurgery·J A MaurielloM C Yepez
Jul 16, 2008·Current Opinion in Otolaryngology & Head and Neck Surgery·Fred G Fedok
Apr 15, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A R BentivoglioA Albanese
Sep 1, 1996·Acta Neurologica Scandinavica·R S ChenC H Tsai
Dec 1, 1996·The British Journal of Ophthalmology·J A MaurielloM C Yepez
Aug 26, 1998·The British Journal of Ophthalmology·J M Olver
Jul 1, 1998·Journal of Neurology, Neurosurgery, and Psychiatry·S JitpimolmardM Laopaiboon
Jul 15, 1988·American Journal of Ophthalmology·B R FruehD C Musch
Jan 17, 2002·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·G T Drummond, B J Hinz
Jul 31, 2001·Ophthalmic Plastic and Reconstructive Surgery·R G Fante, B R Frueh
Mar 22, 2006·Ophthalmic Plastic and Reconstructive Surgery·Petros AristodemouCharles Hugkulstone
Mar 22, 2008·Ophthalmic Plastic and Reconstructive Surgery·Andrew R HarrisonMichael S Lee
Aug 19, 2007·Current Opinion in Ophthalmology·Altug Cetinkaya, Paul A Brannan
Dec 1, 1993·Ophthalmology·R M SiatkowskiW J Feuer
Aug 1, 1996·Ophthalmology·A J Flach
Jan 11, 2007·Survey of Ophthalmology·Jonathan J Dutton, Amy M Fowler
Jul 1, 1991·Survey of Ophthalmology·M Osako, J L Keltner
Oct 11, 2005·Otolaryngologic Clinics of North America·Stuart R Seiff, Orin M Zwick
Jun 1, 1987·Acta Ophthalmologica·P Ruusuvaara, K Setälä
Aug 1, 1988·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·S P Kraft, A E Lang
Dec 21, 2020·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·Vikram SinhaNaveen Cavale

❮ Previous
Next ❯

Related Concepts

Related Feeds

Botulism (ASM)

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Botulism

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.